Start Date
2018
Description
- Group B Streptococcus (GBS) colonizes 10-30% of women.
- GBS remains the leading cause of infectious neonatal morbidity and mortality1
- GBS is defined as being β-hemolytic, but about 3% of strains are non-hemolytic.
- Recent data suggest that non-hemolytic strains also pose health risks to infants2.
- Previous data from our lab demonstrated that GB37 is non-hemolytic when grown on blood agar, but is hemolytic when grown in suspension with red blood cells.
Recommended Citation
Harlow, Olivia S.; Anumolu, Natalie; Manning, Shannon; and Boldenow, Erica, "Hemolytic and Non-Hemolytic Group B Streptococcus Strains’ Impact on Infection and Inflammation in Human Placental and Immune Cells" (2018). Summer Research. 21.
https://digitalcommons.calvin.edu/summer_research/2018/Posters/21
Included in
Jan 1st, 12:00 AM
Hemolytic and Non-Hemolytic Group B Streptococcus Strains’ Impact on Infection and Inflammation in Human Placental and Immune Cells
- Group B Streptococcus (GBS) colonizes 10-30% of women.
- GBS remains the leading cause of infectious neonatal morbidity and mortality1
- GBS is defined as being β-hemolytic, but about 3% of strains are non-hemolytic.
- Recent data suggest that non-hemolytic strains also pose health risks to infants2.
- Previous data from our lab demonstrated that GB37 is non-hemolytic when grown on blood agar, but is hemolytic when grown in suspension with red blood cells.